Senior insider sale
Chief Scientific Officer at ARBUTUS BIOPHARMA CORP — senior position signals high conviction
$550.0K
167.16K shares
What this filing means
SOFIA MICHAEL J. plans to sell 167.16K shares of ARBUTUS BIOPHARMA CORP valued at approximately $550.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/7/2025ACC: 0001959173-25-001825
Officer· Chief Scientific Officer
Since Jul 2018
167.16K
Shares to sell
$550.0K
Approx. market value
167.16K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Gift
N/A
9/26/2012
70.71KGift
N/A
9/26/2012
96.46KTotal acquired167.16K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/26/2012 | Gift N/A | 70.71K | — |
9/26/2012 | Gift N/A | 96.46K | — |
| Total | 167.16K | ||
Planned & Completed Dispositions1
nasdaqPlanned
Units to sell
167.16K
Market value
$550.0K
3/7/2025
Total
Units
167.16K
Value
$550.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/7/2025 | 167.16K | $550.0K | nasdaq | Planned |
| Total | 167.16K | $550.0K | ||